VON RICKENBACH JOSEF H
SEC Form 4 insider trading activity
VON RICKENBACH JOSEF H has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: May 29, 2026.
On the most recent filing, VON RICKENBACH JOSEF H is listed as Director at Rein Therapeutics, Inc. Inside the rolling window, VON RICKENBACH JOSEF H reported 4 open-market purchases totaling $50K in RNTX and no open-market sales. The largest disclosed transaction in the window is a purchase of 23,190 RNTX shares on May 26, 2026, worth $24K.
Companies traded
Other insiders at RNTX
Insider Buying
$50K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has VON RICKENBACH JOSEF H made?
VON RICKENBACH JOSEF H has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company since 2026.
Which companies does VON RICKENBACH JOSEF H trade?
VON RICKENBACH JOSEF H has filed SEC Form 4 disclosures for 1 company, including RNTX.
When was VON RICKENBACH JOSEF H's most recent SEC Form 4 filing?
VON RICKENBACH JOSEF H's most recent SEC Form 4 filing on Tracefour is dated May 29, 2026.
What is VON RICKENBACH JOSEF H's total buy and sell value in the current window?
Inside the rolling retention window, VON RICKENBACH JOSEF H bought $50K and sold $0 based on SEC Form 4 filings.
What was VON RICKENBACH JOSEF H's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 23,190 RNTX shares on 2026-05-26, worth $24K, per SEC Form 4 filings.